Feed aggregator

Apellis Eye Injection Treatment Flagged for Safety Issues

Biospace news - Mon, 07/31/2023 - 02:00
Apellis Eye Injection Treatment Flagged for Safety Issues 7/31/2023

Early-Stage Biopharma Funding to Drop 40% This Year: Report

Biospace news - Mon, 07/31/2023 - 02:00
Early-Stage Biopharma Funding to Drop 40% This Year: Report 7/31/2023

House Republicans Propose Drug Shortage Legislation After Gutting Democrats’ Bill

Biospace news - Mon, 07/31/2023 - 02:00
House Republicans Propose Drug Shortage Legislation After Gutting Democrats’ Bill 7/31/2023

Demise of Intercept’s NASH Program Highlights Safety Hurdles Facing the Space

Biospace news - Mon, 07/31/2023 - 02:00
Demise of Intercept’s NASH Program Highlights Safety Hurdles Facing the Space 7/31/2023

FDA Action Alert: Mesoblast, Sage/Biogen and Galera

Biospace news - Mon, 07/31/2023 - 02:00
FDA Action Alert: Mesoblast, Sage/Biogen and Galera 7/31/2023

Sana Biotechnology Advances R&D Platform to Overcome Immune Rejection

Biospace news - Mon, 07/31/2023 - 02:00
Sana Biotechnology Advances R&D Platform to Overcome Immune Rejection 7/31/2023

New RNA-based therapy combats melanoma in mouse models

World Pharma News - Fri, 07/28/2023 - 10:00
Investigators at the Icahn School of Medicine at Mount Sinai have designed an innovative RNA-based strategy to activate dendritic cells - which play a key role in immune response - that eradicated tumors and prevented their recurrence in mouse models of melanoma.

The findings, which suggest that the approach has the potential to be effective against tumors that have already spread to other parts of the body and against different cancer types,

Week in Review: Biogen M&A and Layoffs, Earnings Season Heats Up, and 12 Neuro Companies to Watch

Biospace news - Fri, 07/28/2023 - 02:00
Week in Review: Biogen M&A and Layoffs, Earnings Season Heats Up, and 12 Neuro Companies to Watch 7/28/2023

Biogen Boosts Neuro Pipeline with $7.3B Reata Buy Amid Layoffs

Biospace news - Fri, 07/28/2023 - 02:00
Biogen Boosts Neuro Pipeline with $7.3B Reata Buy Amid Layoffs 7/28/2023

AstraZeneca, Pfizer Ink Potential $1B Gene Therapy Deal

Biospace news - Fri, 07/28/2023 - 02:00
AstraZeneca, Pfizer Ink Potential $1B Gene Therapy Deal 7/28/2023

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year

Biospace news - Fri, 07/28/2023 - 02:00
5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year 7/28/2023

Merck’s Pneumococcal Shot Claims Back-to-Back Phase III Wins

Biospace news - Fri, 07/28/2023 - 02:00
Merck’s Pneumococcal Shot Claims Back-to-Back Phase III Wins 7/28/2023

Takeda Likely to Drop Rare Genetic Disease Candidate After Phase II Fail

Biospace news - Fri, 07/28/2023 - 02:00
Takeda Likely to Drop Rare Genetic Disease Candidate After Phase II Fail 7/28/2023

Pfizer announces executive leadership to advance oncology research and development strategy

World Pharma News - Thu, 07/27/2023 - 10:00
Pfizer Inc. (NYSE: PFE) today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology.

Effective today, Chris Boshoff, M.D., PhD, will join Pfizer's Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to

Lilly’s Tirzepatide Cuts Weight of Enrollees by 26% in Phase III Trials

Biospace news - Thu, 07/27/2023 - 02:00
Lilly’s Tirzepatide Cuts Weight of Enrollees by 26% in Phase III Trials 7/27/2023

BMS Reports Q2 Sales Miss Amid Generic Competition, Lowers Full-Year Guidance

Biospace news - Thu, 07/27/2023 - 02:00
BMS Reports Q2 Sales Miss Amid Generic Competition, Lowers Full-Year Guidance 7/27/2023

Roche Drops Hemophilia A Candidate, Prepares for the Impacts of IRA

Biospace news - Thu, 07/27/2023 - 02:00
Roche Drops Hemophilia A Candidate, Prepares for the Impacts of IRA 7/27/2023

Alkermes Gets $248M Boost from J&J, Gives Bullish Outlook on Teva Legal Fight

Biospace news - Thu, 07/27/2023 - 02:00
Alkermes Gets $248M Boost from J&J, Gives Bullish Outlook on Teva Legal Fight 7/27/2023

Sage Stock Drops Despite Promising Phase III Depression Data

Biospace news - Thu, 07/27/2023 - 02:00
Sage Stock Drops Despite Promising Phase III Depression Data 7/27/2023

Opinion: The Power of Credibility—How Emerging Biotechs Can Earn Candidates’ Trust

Biospace news - Thu, 07/27/2023 - 02:00
Opinion: The Power of Credibility—How Emerging Biotechs Can Earn Candidates’ Trust 7/27/2023